These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. Haddad F; Perez M; Fleischmann D; Valantine H; Hunt SA J Heart Lung Transplant; 2006 Nov; 25(11):1367-70. PubMed ID: 17097503 [TBL] [Abstract][Full Text] [Related]
28. [Mechanisms of transplant vasculopathy]. Baron H; Plenz G; Deng MC Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400 [TBL] [Abstract][Full Text] [Related]
29. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy. Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881 [TBL] [Abstract][Full Text] [Related]
30. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy. Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549 [TBL] [Abstract][Full Text] [Related]
31. Proliferation signal inhibitors and cardiac allograft vasculopathy. Raichlin E; Kushwaha SS Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540 [TBL] [Abstract][Full Text] [Related]
32. Novel roles of OX40 in the allograft response. Demirci G; Li XC Curr Opin Organ Transplant; 2008 Feb; 13(1):26-30. PubMed ID: 18660703 [TBL] [Abstract][Full Text] [Related]
33. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794 [TBL] [Abstract][Full Text] [Related]
34. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779 [TBL] [Abstract][Full Text] [Related]
35. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation. Delgado JF; Manito N; Segovia J; Almenar L; Arizón JM; Campreciós M; Crespo-Leiro MG; Díaz B; González-Vílchez F; Mirabet S; Palomo J; Roig E; de la Torre JM Transplant Rev (Orlando); 2009 Apr; 23(2):69-79. PubMed ID: 19298938 [TBL] [Abstract][Full Text] [Related]
36. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360 [TBL] [Abstract][Full Text] [Related]
37. Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia. Soleimani B; Wieczorek G; Katopodis A; Zenke G; George AJ; Hornick PI; Weitz-Schmidt G J Heart Lung Transplant; 2007 Jul; 26(7):724-31. PubMed ID: 17613404 [TBL] [Abstract][Full Text] [Related]